Robertson Jenny 4
4 · Lexeo Therapeutics, Inc. · Filed Apr 9, 2025
Insider Transaction Report
Form 4
Robertson Jenny
Chief Legal Officer
Transactions
- Award
Common Stock
2025-03-14$2.61/sh+5,720$14,929→ 63,619 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]Includes 54,062 restricted stock units.